Oral Health Group
News

Dentsply Sirona Acquires Cleverdent Ltd.


January 18, 2018
by Dentsply Sirona

Dentsply Sirona today announced the definitive agreement to acquire Cleverdent Limited. Cleverdent Ltd. developed the ClasenUNO®  an innovative fusion of a dental mirror and high volume evacuation (HVE) tip which perfectly complements Dentsply Sirona’s portfolio.

Dentsply Sirona is committed to its Mission of empowering dental professionals to provide better, safer, faster dental care through the combination best in class technologies and clinical education, sales support and customer service. With the addition of Cleverdent Ltd.to Dentsply Sirona, dental professionals will benefit from a more efficient workflow across multiple procedures.

ClasenUNO creates efficiency for clinicians performing two-handed dentistry and reduces the need for four-handed procedures by enabling assistants to complete other tasks. The benefit of indirect vision and illumination through the mirror combined with high volume evacuation (HVE) can be used across multiple wet and dry procedures, with preventive and restorative applications, including ultrasonic scaling and air polishing procedures.

“This product provides our customers with innovative technology and enhances Dentsply Sirona’s dental procedures to support more efficient clinical outcomes”, Mark Trimmer, Interim Group Vice President Global Preventives, commented.

Stephan Clasen, Cleverdent Ltd. owner and dentist, developed and patented ClasenUNO in collaboration with a team of technical, design and materials specialists. Since 1999 Stephan Clasen has been running his own dental practice in Münster, Germany, with main focus on endodontics, periodontics, function diagnostics and holistic dental medicine. ClasenUNO, a pioneering fusion of dental mirror and high volume evacuation (HVE) tip, was first introduced at the 2015 International Dental Show and successfully launched in the German, Holland and Italian markets. It has since expanded into France, Portugal, Switzerland and South Africa.   

Combining innovation and appealing aesthetics, the device was given the 2016 iF Design Award in the Medicine/Healthcare category. For more than 60 years, the iF Design Award has been recognized around the world as a trademark for design excellence. More than 5,000 entrants from 53 countries applied for the esteemed seal of quality. 

About Cleverdent:
Cleverdent is a British company with its headquarter in Münster, Germany. It was founded in 2004 by Dentist Stephan Clasen and Dr. Martin Kayser. Purpose of the company was the development and marketing of ClasenUNO, a device invented by Clasen. From the beginning Cleverdent has cooperated with engineers and specialists in the areas of moulding and mirror technology. Since 2009 Cleverdent has also engaged Heinz-Jürgen Gerdes, a design and marketing expert specialized in bringing innovative ideas to market success.


ABOUT DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 130-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry.  Dentsply Sirona’s global headquarters is located in York, Pennsylvania, and the international headquarters is based in Salzburg, Austria. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products. 

DISCLAIMER
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.